LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹32 Cr |
Mar2024 | ₹32 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹43 Cr |
Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹32 Cr | 0.35 | |
Mar2024 | ₹32 Cr | -7.30 | |
Mar2023 | ₹34 Cr | -20.24 | |
Mar2022 | ₹43 Cr | 3.93 | |
Mar2021 | ₹41 Cr | - |
Compare Contingent Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹354.7 Cr | 0.8% | -0.3% | -34.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 0.8% |
-0.3% |
-34.5% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses